Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000514954 | SCV000610682 | likely benign | not provided | 2017-02-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000514954 | SCV002298994 | uncertain significance | not provided | 2024-10-15 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 1117 of the HTT protein (p.Ala1117Gly). This variant is present in population databases (rs1065747, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with HTT-related conditions. ClinVar contains an entry for this variant (Variation ID: 445887). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV000514954 | SCV004700498 | likely benign | not provided | 2025-03-01 | criteria provided, single submitter | clinical testing | HTT: BP4 |